Atlas of Cholescintigraphy: Selective Update

  • Harvey A. Ziessman
Part of the Atlases of Clinical Nuclear Medicine book series (ATLASES)

Abstract

Cholescintigraphy has proven to be the imaging study of choice for the diagnosis of acute cholecystitis and has been found quite useful for the diagnosis and evaluation of a variety of other hepatobiliary diseases. Several atlases of radionuclide hepatobiliary imaging have previously been published.1–3 This atlas describes and illustrates recent advances in cholescintigraphy. The emphasis is on newly described scintigraphic findings helpful in diagnosis as well as improvements or modifications in technique and computer processing.

Keywords

Fatigue Adenoma Pancreatitis Radionuclide Bilirubin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Blue PW. Hepatobiliary imaging in patients without prior surgery. In: Van Nostrand D and Baum S, eds. Atlas of Nuclear Medicine. Philadelphia: JB Lippincott Co; 1988:41–51.Google Scholar
  2. 2.
    Kuni CC, Klingensmith WC, eds. Atlas of Radionuclide Hepatobiliary Imaging. Boston: GK Hall Medical Publishers; 1983.Google Scholar
  3. 3.
    Weissmann HS, Sugarman LA, Freeman LM. Atlas of Tc-99m iminodiacetic acid (IDA) cholescintigraphy. Clin Nucl Med. 1982;7:231–239.PubMedCrossRefGoogle Scholar
  4. 4.
    Weissman HS, Berkowitz D, Fox MS, Gliedman ML, Rosenblatt R, Sugarman LA, Freeman LM. The role of technetium-99m iminodiacetic acid (IDA) cholescintigraphy in acute acalculous cholecystitis. Radiology. 1983;146:177–180.Google Scholar
  5. 5.
    Krishnamurthy GT, Turner FE. Pharmacokinetics and clinical applications of technetium 99m-labeled hepatobiliary agents. Sem Nucl Med. 1990;20:130–149.CrossRefGoogle Scholar
  6. 6.
    Chaudhuri TK, Fink S. Physiologic considerations in radionuclide imaging of the extrahepatic biliary tract. Am J Phys Imaging. 1988;3:114–120.Google Scholar
  7. 7.
    Weissmann HS, Badia J, Sugarman LA, et al. Spectrum of cholescintigraphic patterns in acute cholecystitis. Radiology. 1981;138:167–175.PubMedGoogle Scholar
  8. 8.
    Freitas JE, Coleman RE, Nagle CE, Bree RL, Kremer KD, Gross M. Influence of scan and pathological criteria on the specificity of cholescintigraphy. J Nucl Med. 1983;24:876–879.PubMedGoogle Scholar
  9. 9.
    Weissmann HS, Freeman LM. The biliary tract. In: Freeman LM, ed. Freeman and Johnson’s Clinical Radionuclide Imaging, 3rd ed. New York: Grune & Stratton; 1984: 916–1049.Google Scholar
  10. 10.
    Kim CK, Palestro CJ, Solomon RW, Molinari DS, Lee SO, Goldsmith SJ. Delayed biliary-bowel transit in cholescintigraphy after cholecystokinin treatment. Radiology. 1990;176:553–556.PubMedGoogle Scholar
  11. 11.
    Drane WE. Gallbladder visualization after hepatic washout. Clin Nucl Med. 1987;12:453–456.PubMedCrossRefGoogle Scholar
  12. 12.
    Choy D, Shi EC, McLean RG, et al. Cholescintigraphy in acute cholecystitis: use of intravenous morphine. Radiology. 1984;151:203–207.PubMedGoogle Scholar
  13. 13.
    Fig LM, Wahl RL, Stewart RE, Shapiro B. Morphine-augmented hepatobiliary scintigraphy in the severely ill: caution is in order. Radiology. 1990;175:467–473.PubMedGoogle Scholar
  14. 14.
    Kistler AM, Ziessman HA, Gooch D, Bitterman P. Utility of morphine-augmented hepatobiliary scanning in evaluation of acute cholecystitis. Clin Nucl Med. 1991;16:404–406.PubMedCrossRefGoogle Scholar
  15. 15.
    Vasquez TE, Rimkus DS, Pretorius HT, Greenspan G. Intravenous administration of morphine sulfate in hepatobiliary imaging for acute cholecystitis: a review of clinical efficacy. Nucl Med Commun. 1988;9:217–222.PubMedCrossRefGoogle Scholar
  16. 16.
    Kim EE, Pjura G, Lowre P, Nguyen M, Pollack M. Morphine-augmented cholescintigraphy in the diagnosis of acute cholecystitis. AJR. 1986;147:1177–1179.PubMedGoogle Scholar
  17. 17.
    Mock JM, Slavin JD Jr, Spencer RP. Two false negative results using morphine sulfate in hepatobiliary imaging. Clin Nucl Med. 1989;141:87–88.CrossRefGoogle Scholar
  18. 18.
    Brachman MB, Tanasescu DE, Ramanna L, Waxman AD. Acute gangrenous cholecystitis: radionuclide diagnosis. Radiology. 1984;151:209–211.PubMedGoogle Scholar
  19. 19.
    Smith R, Rosen JM, Alderson PO. Gallbladder perforation: diagnostic utility of cholescintigraphy in suggested subacute or chronic cases. Radiology. 1986;158:63–66.PubMedGoogle Scholar
  20. 20.
    Meekin GK, Ziessman HA, Klappenbach RS. Prognostic value and pathophysiologic significance of the rim sign in cholescintigraphy. J Nucl Med. 1987;28:1679–1682.PubMedGoogle Scholar
  21. 21.
    Swayne LC, Ginsberg HN. Diagnosis of acute cholecystitis by cholescintigraphy: significance of pericholecystic hepatic uptake. AJR. 1989;152:1211–1213.PubMedGoogle Scholar
  22. 22.
    Bushnell DL, Perlman SB, Wilson MA, et al. The rim sign: association with acute cholecystitis. J Nucl Med. 1986;27:353–356.PubMedGoogle Scholar
  23. 23.
    Colletti PM, Cirimelli KM, Radin DR, et al. Radionuclide angiography in suspected acute cholecystitis: further observations. Clin Nucl Med. 1989;14:867–873.PubMedCrossRefGoogle Scholar
  24. 24.
    Colletti PM, Ralls PW, Siegel ME, Halls JM. Acute cholecystitis: diagnosis with radionuclide angiography. Radiology. 1987;163:615–618.PubMedGoogle Scholar
  25. 25.
    Rogers JV, Mack L, Freeny PC, Johnson ML, Sones PJ. Hepatic focal nodular hyperplasia: angiography, TCT, sonography, and scintigraphy. AJR. 1981;137:983–990.PubMedGoogle Scholar
  26. 26.
    Tanasescu D, Brachman M, Rigby J, et al. Scintigraphic triad in focal nodular hyperplasia. Am J Gastroenterol. 1984;79:61–64.PubMedGoogle Scholar
  27. 27.
    Biersack HJ, Thelen M, Torres JF, et al. Focal nodular hyperplasia of the liver as established by 99mTc sulfur colloid and HIDA scintigraphy. Radiology. 1980;137:187–190.PubMedGoogle Scholar
  28. 28.
    Hasegawa Y, Nakano S, Ibuka T, et al. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent. J Nucl Med. 1984;25:1122–1126.PubMedGoogle Scholar
  29. 29.
    Calvet X, Pons F, Bruix J, et al. Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation. J Nucl Med. 1988;29:1916–1920.PubMedGoogle Scholar
  30. 30.
    Kipper MS, Reed KR, Contardo M. Visualization of hepatic adenoma with Tc-99m di-isopropyl IDA. J Nucl Med. 1984;25:986–988.PubMedGoogle Scholar
  31. 31.
    Gratz KF, Creutzig H, Brolsch C, et al. Choleszintigraphie zum nachweis der focal-nodularen hyperplasie (FNH) der leber? Chirurg. 1984;55:448–451.PubMedGoogle Scholar
  32. 32.
    Kotzerke J, Schwarzrock R, Krischek O, Wiese H, Hundeshagen H. Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. J Nucl Med. 1989;30:1278–1279.PubMedGoogle Scholar
  33. 33.
    Rodman CA, Keefe EB, Lieberman DA, et al. Diagnosis of sclerosing cholangitis with technetium 99m-labeled iminodiacetic acid planar and single photon emission computed tomographic scintigraphy. Gastroentrology. 1987;92:777–785.Google Scholar
  34. 34.
    Béla, Halpert. In: Anderson WHD, ed. Pathology, Chapter 29. St. Louis: CV Mosby Co; 1971:1261–1265.Google Scholar
  35. 35.
    Fink-Bennett D. The role of cholecystogogues in the evaluation of biliary tract disorders. In: Freeman LM, Weissmann HS, eds. Nuclear Medicine Annual. New York: Raven Press, 1985.Google Scholar
  36. 36.
    Swayne L, Palace F, Rothenberg J, et al. Sensitivity, specificity, and accuracy of CCK cholescintigraphy in acalculous biliary disease. J Nucl Med. 1986;27:882–883. Abstract.Google Scholar
  37. 37.
    Brugge WR, Brand DDL, Atkins JL, et al. Gallbladder dyskinesia in chronic acalculous cholecystitis. Dig Dis Sci. 1986;31:461–467.PubMedCrossRefGoogle Scholar
  38. 38.
    Topper TE, Ryerson TW, Nora PF. Quantitative gallbladder imaging following cholecystokinin. J Nucl Med. 1980;21:694–696.PubMedGoogle Scholar
  39. 39.
    Westlake PJ, Hershfield NB, Kelly JK, et al. Chronic right upper quadrant pain without gallstones: does HIDA scan predict outcome after cholecystectomy? Am J Gastroenterol. 1990;85:986–990.PubMedGoogle Scholar
  40. 40.
    Davis GB, Berk RN, Scheible FW, et al. Cholecystokinin cholescintigraphy, sonography and scintigraphy: detection of chronic acalculous cholecystitis. AJR. 1982;1139:1117–1121.Google Scholar
  41. 41.
    Weissmann HS, Gliedman MR, Wilk PJ, et al. Evaluation of the postoperative patient with 99mTc-IDA cholescintigraphy. Semin Nucl Med. 1982;12:27–52.PubMedCrossRefGoogle Scholar
  42. 42.
    Cruetzig H, Gratz K, Brolsch C, et al. Diagnosis of bile leakage by cholescintigraphy. J Nucl Med. 1982;23:73.Google Scholar
  43. 43.
    Rosenthall L, Fonseca C, Arzoumanian A, et al. 99mTc-IDA hepatobiliary imaging following upper abdominal surgery. Radiology. 1979;130:735–739.PubMedGoogle Scholar
  44. 44.
    D’Alonzo W, Velchik MG. Post cholecystectomy syndrome due to a cystic duct remnant diagnosed by hepatobiliary scintigraphy. Clin Nucl Med. 1984;9:719.PubMedCrossRefGoogle Scholar
  45. 45.
    Zeman RK, Lee C, Jaffe MH, Burrell JI. Hepatobiliary scintigraphy and sonography in early biliary obstruction. Radiology. 1984;153:793–798.PubMedGoogle Scholar
  46. 46.
    Zeman RK, Burrell MI, Dobbins J, Jaffe MH, Choyke PL. Postcholecystectomy syndrome: evaluation using biliary scintigraphy and endoscopic retrograde cholangiopancreatography. Radiology. 1985;156:787–792.PubMedGoogle Scholar
  47. 47.
    Krishnamurthy GT, Lieberman DA, Brar HS. Detection, localization and quantitation of degree of common bile duct obstruction by scintigraphy. J Nucl Med. 1985;26:726–735.PubMedGoogle Scholar
  48. 48.
    Kloiber R, AuCoin R, Hershfield NB, et al. Biliary obstruction after cholecystectomy: diagnosis with quantitative cholescintigraphy. Radiology. 1988;169:643–647.PubMedGoogle Scholar
  49. 49.
    Darweesh RMA, Dodds WJ, Hogan WJ, et al. Efficacy of quantitative hepatobiliary scintigraphy and fatty-meal sonography for evaluating patients with suspected partial common duct. Gastroenterology. 1988;94:779–786.PubMedGoogle Scholar
  50. 50.
    Steinberg WM. Sphincter of Oddi dysfunction: a clinical controversy. Gastroenterology. 1988;95:1409–1415.PubMedGoogle Scholar
  51. 51.
    Toouli J, Roberts-Thomson, IC, Dent J, Lee J. Manometric disorders in patients with suspected sphincter of Oddi dysfunction. Gastroenterology. 1985:88:1243–1250.PubMedGoogle Scholar
  52. 52.
    Venu RP, Greenen JE. Diagnosis and treatment of diseases of the papilla. Clin Gastroenterol. 1986;15:439–455.PubMedGoogle Scholar
  53. 53.
    Shaffer EA, Hershfield NB, Logan HK, Kloiber R. Cholescintigraphic detection of functional obstruction of the sphincter of Oddi. Effect of papillotomy. Gastroenterology. 1986;90:728–733.PubMedGoogle Scholar
  54. 54.
    Lee RGL, Gregg JA, Koroshetz AM, Hill TC, Clouse ME. Sphincter of Oddi stenosis: diagnosis using hepatobiliary scintigraphy and endoscopic manometry. Radiology. 1985;156:793–796.PubMedGoogle Scholar
  55. 55.
    Pace RF, Chamberlain MJ, Passi RB. Diagnosing papillary stenosis by technetium-99m HIDA scanning. Can J Surg. 1983;26:191–193.PubMedGoogle Scholar
  56. 56.
    Hershfield NB. Diagnosis of sphincter of Oddi dysfunction. Gastroenterology. 1989;95:241.Google Scholar
  57. 57.
    Roberts-Thomson IC. Endoscopic sphincterotomy of the papilla of Vater: an analysis of 300 case. Aust NZ J Med. 1984;14:611–617.CrossRefGoogle Scholar
  58. 58.
    Geenen JE, Hogan WJ, Dodds WJ, et al. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-oddi dysfunction. N Engl J Med. 1989;320:82–87.PubMedCrossRefGoogle Scholar
  59. 59.
    Carr-Locke DL, Bailey I, Neoptolemos J, Leese T, Heath D. Outcome of endoscopic sphincterotomy for papillary stenosois. Gut. 1986;27:A1280.Google Scholar
  60. 60.
    Brough WA, Taylor TV, Torrance HB. The effect of cholecystectomy on duodenogastric reflux in patients with previous peptic ulcer surgery. Scand J Gastroenterol. 1984;19;255–256.Google Scholar
  61. 61.
    Coletti RM, Barakos JA, Siegel ME, et al. Enterogastric reflux in suspected acute cholecystitis. Clin Nucl Med. 1987;12:533–535.CrossRefGoogle Scholar
  62. 62.
    Drane WE, Karvelis K, Johnson DA, Silverman ED. Scintigraphic evaluation of duodenogastric reflux. Problems, pitfalls and technical review. Clin Nucl Med. 1987;12:377–384.PubMedCrossRefGoogle Scholar
  63. 63.
    Brown PH, Juni JE, Lieberman DA, Krishnamurthy GT. Hepatocyte versus biliary disease: a distinction by deconvolutional analysis of technetium-99m IDA time-activity curves. J Nucl Med. 1988;29:623–630.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1992

Authors and Affiliations

  • Harvey A. Ziessman

There are no affiliations available

Personalised recommendations